NDC 54436-112

Tlando

Testosterone Undecanoate

Tlando is a Oral Capsule, Liquid Filled in the Human Prescription Drug category. It is labeled and distributed by Antares Pharma, Inc.. The primary component is Testosterone Undecanoate.

Product ID54436-112_dcd3d0e0-089f-430c-9f1a-1bbbea82e737
NDC54436-112
Product TypeHuman Prescription Drug
Proprietary NameTlando
Generic NameTestosterone Undecanoate
Dosage FormCapsule, Liquid Filled
Route of AdministrationORAL
Marketing Start Date2022-04-15
Marketing CategoryNDA /
Application NumberNDA208088
Labeler NameAntares Pharma, Inc.
Substance NameTESTOSTERONE UNDECANOATE
Active Ingredient Strength113 mg/1
Pharm ClassesAndrogen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]
DEA ScheduleCIII
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 54436-112-20

120 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (54436-112-20)
Marketing Start Date2022-04-15
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Tlando" or generic name "Testosterone Undecanoate"

NDCBrand NameGeneric Name
54436-112Tlandotestosterone undecanoate
67979-511Aveedtestosterone undecanoate
69087-158Jatenzotestosterone undecanoate
69087-198Jatenzotestosterone undecanoate
69087-237Jatenzotestosterone undecanoate
80603-101KyzatrexTESTOSTERONE UNDECANOATE
80603-103KyzatrexTESTOSTERONE UNDECANOATE
80603-105KyzatrexTESTOSTERONE UNDECANOATE

Trademark Results [Tlando]

Mark Image

Registration | Serial
Company
Trademark
Application Date
TLANDO
TLANDO
88616780 not registered Live/Pending
Lipocine Inc.
2019-09-13
TLANDO
TLANDO
88487154 not registered Live/Pending
Lipocine Inc.
2019-06-24
TLANDO
TLANDO
87075975 not registered Dead/Abandoned
Lipocine Inc.
2016-06-17
TLANDO
TLANDO
86925344 not registered Live/Pending
Lipocine Inc.
2016-03-01

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.